My own experience as a cancer patient reinforced how important it is to care for the whole person, not just the disease,” ...

NJ Top Docs has reviewed and approved five physicians at Hunterdon Hematology Oncology for 2026. We are incredibly ...

A Chula Vista family is mourning the sudden death of 27-year-old Roman Padilla from leukemia, less than a year after his ...

The CAR-T Cellular Team at Children’s Hospital of The King’s Daughters is making it easier for children — and their families — to receive hard cancer treatments closer to home. Because they have ...

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced Dr.

In this video, Paolo Tarantino, MD, PhD, an advanced fellow at Dana-Farber Cancer Institute, discusses the “need and appeal” for oncology education to contextualize “emerging and evolving data in ...

Safety and QoL considerations are reshaping sequencing, including avoidance of immunotherapy in certain drivers and adoption ...

Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. ("Terns") (Nasdaq: ...

OhioHealth has started construction on a five‑story cancer center in Columbus, consolidating outpatient oncology services by ...

Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, in a deal designed to bolster the ...